Sunesis Pharmaceuticals (SNSS)

[mick]

$SNSS THEFLY BREAKING NEWS 09-25-2020 [Instant updates and real-time market news.]
SNSS
15:19 09/25/20
Sunesis partner DOT Therapeutics granted FDA orphan designation
The FDA has granted orphan designation to DOT Therapeutics for its treatment of malignant glioma, according to a post to the agency's website.

In March, Dayton Misfeldt, interim CEO of Sunesis, stated along with the company's Q4 earnings report:

"We are also building value in our product pipeline through partnerships.

In December, we partnered vosaroxin with Denovo Biopharma and TAK-580 with DOT Therapeutics-1 to advance these programs to the market." Reference Link

https://thefly.com/landingPageNews.php?id=3166229&headline=SNSS-Sunesis-partner-DOT-Therapeutics-granted-FDA-orphan-designation